CCEL — Cryo-Cell International Share News
0.000.00%
Last trade - 00:00- $29.43m
- $33.44m
- $31.57m
Brief: Cryo-Cell International Q2 Revenue USD 7.8 Million
Cryo-Cell Q2 revenue falls as processing, storage fees decline
Brief: Cryo-Cell receives acceptance of compliance plan from NYSE
Cryo-Cell International 2025 revenue dips
Brief: Cryo Cell International Inc - On Oct 18, Co Entered Fifth Amendment To Credit Agreement - SEC Filing
Cryo-Cell International Q3 revenue, net income fall
Brief: Cryo-Cell International Q1 Revenue USD 7.97 Million
Brief: Cryo-Cell International Inc - Declares Initiation Of Regular Quarterly Cash Dividend
Brief: Cryo-Cell To Explore Strategic Alternatives, Spin-off Celle
Brief: Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results
Brief: Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results
Brief: Cord Blood Banking Leader Cryo-Cell Reports Fiscal Q1 2023 Financial Results
Brief: Cryo-Cell International Inc - On March 3, Entered Clinical Study And Research Agreement With Duke To Provide Funding To Complete Duke Impact Study
Brief: Cryo-Cell International Reports Qtrly EPS $0.06
Brief: Cryo-Cell Announces Transfer To NYSE American Stock Exchange
Brief: Cryo-Cell International Says Entered Into Credit Agreement For Revolving Credit Facility Of Up To $10 Mln
Brief: Cryo-Cell Reports Fiscal Q2 2022 Financial Results
Brief: Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results
Brief: Cryo-Cell International Inc Announces Extravault Biorepository Service